BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to SUM149PT cell line is 502
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | Paclitaxel | ALDEFLUOR assay and SFA followed by Western Blotting and qPCR | NA | 0.6 | 0.684 | 28703802 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | ALDEFLUOR assay followed by SFA | NA | 0.6 | 0.684 | 33674749 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | ALDEFLUOR assay followed by SFA | NA | 0.6 | 0.684 | 35135840 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | ALDEFLUOR assay followed by SFA | NA | 0.6 | 0.684 | 35508987 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | SFA followed by FACs | NA | 0.6 | 0.684 | 35357654 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | ALDEFLUOR assay followed by SFA | NA | 0.6 | 0.684 | 19190339 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | ALDEFLUOR assay followed by SFA | NA | 0.6 | 0.684 | 29027990 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | ALDEFLUOR assay followed by SFA | NA | 0.6 | 0.684 | 30052635 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | ALDEFLUOR assay followed by SFA | NA | 0.6 | 0.684 | 30344009 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | ALDEFLUOR assay followed by Tumorigenicity assay | NA | 0.6 | 0.684 | 30632269 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | SFA followed by ALDEFLUOR assay | NA | 0.6 | 0.684 | 28978083 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | SFA followed by ALDEFLUOR assay | NA | 0.6 | 0.684 | 29471829 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | SFA followed by FACs | NA | 0.6 | 0.684 | 30242135 |
| NANOG | 20857 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | qRT-PCR and Western Blotting | NA | 0.48 | 0.5461 | 30542507 |
| NANOG | 20857 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | MK-0752 | qRT-PCR followed by SFA | NA | 0.48 | 0.5461 | 29027990 |
| NANOG | 20857 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | RT-PCR followed by SFA | NA | 0.48 | 0.5461 | 29471829 |
| NANOG | 20857 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | Paclitaxel | SFA followed by qPCR | NA | 0.48 | 0.5461 | 28703802 |
| POU5F1 | 9221 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | qRT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 30542507 |
| POU5F1 | 9221 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | Paclitaxel | SFA followed by qPCR and Western Blotting | NA | 0.48 | 0.6448 | 28703802 |
| POU5F1 | 9221 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | qPCR followed by SFA | NA | 0.48 | 0.6448 | 35135840 |
| POU5F1 | 9221 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | MK-0752 | qRT-PCR followed by SFA | NA | 0.48 | 0.6448 | 29027990 |
| POU5F1 | 9221 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | RT-PCR followed by SFA | NA | 0.48 | 0.6448 | 29471829 |
| SOX2 | 11195 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | qRT-PCR and Western Blotting | NA | 0.48 | 0.5695 | 30542507 |
| SOX2 | 11195 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | qPCR followed by SFA | NA | 0.48 | 0.5695 | 35135840 |
| SOX2 | 11195 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | MK-0752 | qRT-PCR followed by SFA | NA | 0.48 | 0.5695 | 29027990 |
| SOX2 | 11195 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | RT-PCR followed by SFA | NA | 0.48 | 0.5695 | 29471829 |
| SOX2 | 11195 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | Paclitaxel | SFA followed by qPCR | NA | 0.48 | 0.5695 | 28703802 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | Paclitaxel | FACs and SFA followed by Western Blotting | NA | 0.4 | 1 | 28703802 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs followed by SFA | NA | 0.4 | 1 | 35508987 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | SFA followed by FACs | NA | 0.4 | 1 | 35357654 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs | NA | 0.4 | 1 | 29620216 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs | NA | 0.4 | 1 | 31709178 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs | NA | 0.4 | 1 | 31729259 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs followed by CFA | NA | 0.4 | 1 | 18366788 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | MK-0752 | FACs followed by SFA | NA | 0.4 | 1 | 29027990 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | RO49097 | FACs followed by SFA | NA | 0.4 | 1 | 29027990 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs followed by SFA | NA | 0.4 | 1 | 30227220 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs followed by SFA | NA | 0.4 | 1 | 30542507 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs followed by Tumorigenicity assay | NA | 0.4 | 1 | 30050079 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | SFA followed by FACs | NA | 0.4 | 1 | 28951456 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | SFA followed by FACs | NA | 0.4 | 1 | 28978083 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | SFA followed by FACs | NA | 0.4 | 1 | 29975921 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | NA | 0.4 | 1 | 31709178 |
| ADORA2B | 264 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | SFA followed by qRT-PCR and FACs | NA | 0.32 | 0.0042 | 30242135 |
| IL6 | 6018 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.28 | 0.0191 | 31709178 |
| IL6 | 6018 | HTM/LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics and qPCR | Up | 0.28 | 0.0191 | 31729259 |
| IL6 | 6018 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | MK-0752 | Western Blotting followed by SFA | NA | 0.28 | 0.0191 | 29027990 |
| IL6 | 6018 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | RO49097 | Western Blotting followed by SFA | NA | 0.28 | 0.0191 | 29027990 |
| IL6 | 6018 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | Paclitaxel | qPCR followed by SFA | NA | 0.28 | 0.0191 | 28703802 |
| FA2H | 21197 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.24 | 0.0042 | 31709178 |
| FA2H | 21197 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.24 | 0.0042 | 31709178 |
| TGFBR2 | 11773 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.24 | 0.0032 | 31709178 |
| TGFBR2 | 11773 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.24 | 0.0032 | 31709178 |
| FA2H | 21197 | HTM/LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics and qPCR | Up | 0.24 | 0.0042 | 31729259 |
| TGFBR2 | 11773 | HTM/LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics and qPCR | Up | 0.24 | 0.0032 | 31729259 |
| CCL20 | 10619 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.2 | 0.0074 | 31709178 |
| BCL6 | 1001 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0032 | 35357654 |
| CCL20 | 10619 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | qRT-PCR followed by SFA | NA | 0.2 | 0.0074 | 30052635 |
| CCR6 | 1607 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | qRT-PCR followed by SFA | NA | 0.2 | 0.0011 | 30052635 |
| IL8 | 6025 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | Paclitaxel | qPCR followed by SFA | NA | 0.2 | 0.0159 | 28703802 |
| MYC | 7553 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | qPCR followed by SFA | NA | 0.2 | 0.1304 | 35135840 |
| MYC | 7553 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | Paclitaxel | SFA followed by qPCR | NA | 0.2 | 0.1304 | 28703802 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs followed by SFA | NA | 0.12 | 0.456 | 35508987 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs | NA | 0.12 | 0.456 | 29620216 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs | NA | 0.12 | 0.456 | 31709178 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs | NA | 0.12 | 0.456 | 31729259 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | Paclitaxel | FACs and SFA | NA | 0.12 | 0.456 | 28703802 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs followed by CFA | NA | 0.12 | 0.456 | 18366788 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | MK-0752 | FACs followed by SFA | NA | 0.12 | 0.456 | 29027990 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | RO49097 | FACs followed by SFA | NA | 0.12 | 0.456 | 29027990 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs followed by SFA | NA | 0.12 | 0.456 | 30227220 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs followed by SFA | NA | 0.12 | 0.456 | 30542507 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs followed by Tumorigenicity assay | NA | 0.12 | 0.456 | 30050079 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | SFA followed by FACs | NA | 0.12 | 0.456 | 28951456 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | SFA followed by FACs | NA | 0.12 | 0.456 | 28978083 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | SFA followed by FACs | NA | 0.12 | 0.456 | 29975921 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | NA | 0.12 | 0.456 | 31709178 |
| EPCAM | 11529 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs followed by CFA | NA | 0.12 | 0.211 | 18366788 |
| EPCAM | 11529 | LTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | SFA followed by FACs | NA | 0.12 | 0.211 | 28951456 |
| A2ML1 | 23336 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| AARD | 33842 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ABCA12 | 14637 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| ABCA4 | 34 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ABCC2 | 53 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0106 | 31709178 |
| ACE | 2707 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ACE2 | 13557 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ACOT11 | 18156 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ACOXL | 25621 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ACP3 | 125 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ACP7 | 33781 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ADGRG3 | 13728 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| AGR2 | 328 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0064 | 31709178 |
| AGR2 | 328 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0064 | 31729259 |
| ALDH3B2 | 411 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ALDH5A1 | 408 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ALOX12B | 430 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ALOX15B | 434 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ALOX15B | 434 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| AP3B2 | 567 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| APBA2 | 579 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| ARHGAP42 | 26545 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ARMH1 | 34345 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ARSI | 32521 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ATP6V1B1 | 853 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| ATP8A2 | 13533 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| B4GALNT3 | 24137 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| BCL2L14 | 16657 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| BGN | 1044 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| BICDL1 | 28095 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| BMP4 | 1071 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| C11ORF86 | 34442 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| C17ORF107 | 37238 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| C19ORF38 | 34073 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| C1ORF210 | 28755 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| C4ORF19 | 25618 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CALB1 | 1434 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CAMK2A | 1460 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| CASC9 | 48906 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| CASP14 | 1502 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CBLC | 15961 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| CCL22 | 10621 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CCNA1 | 1577 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CD22 | 1643 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CD24P4 | 1649 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| CDH1 | 1748 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0053 | 31709178 |
| CDH13 | 1753 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| CDH26 | 15902 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| CES1 | 1863 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| CFL2 | 1875 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31729259 |
| CHI3L2 | 1933 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CKMT1B | 1995 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CLEC7A | 14558 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CLIC3 | 2064 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| CMAHP | 2098 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| COBL | 22199 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| COL5A1 | 2209 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| COL8A1 | 2215 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| COL9A3 | 2219 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CPLX1 | 2309 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| CPVL | 14399 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CRIP1 | 2360 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| CSGALNACT1 | 24290 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| CYP24A1 | 2602 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| CYP4F3 | 2646 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| DAPK1 | 2674 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| DDR1 | 2730 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| DHDH | 17887 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| DIO3 | 2885 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| DKK3 | 2893 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| DLL4 | 2910 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| DLX3 | 2916 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| DMKN | 25063 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| DMTN | 3382 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| DNAJA4 | 14885 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| DSC3 | 3037 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| DSCR8 | 16707 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| DSP | 3052 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| DUOX1 | 3062 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| DUOX2 | 13273 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| E2F2 | 3114 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| EDN1 | 3176 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0053 | 31709178 |
| ELOVL3 | 18047 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| EMBP1 | 38661 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ENPP2 | 3357 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| ENTPD3 | 3365 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ENTPD8 | 24860 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| EPN3 | 18235 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| EPPIN | 15932 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ESPN | 13281 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ESR1 | 3467 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| EXOC3L4 | 20120 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| F2R | 3537 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| FAAH | 3553 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| FAAH2 | 26440 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| FADS2 | 3575 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0064 | 31709178 |
| FAM126A | 24587 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31729259 |
| FAM50B | 18789 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| FAM71E1 | 25107 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| FAM71E2 | 25278 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| FAM71F1 | 30704 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| FAM83F | 25148 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| FBP1 | 3606 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| FBP1 | 3606 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31729259 |
| FBXO27 | 18753 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| FCMR | 14315 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| FDCSP | 19215 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| FFAR2 | 4501 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| FGFBP1 | 19695 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| FGFR1 | 3688 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0053 | 31709178 |
| FGFR2 | 3689 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| FLT1 | 3763 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| FMN2 | 14074 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| FOLR1 | 3791 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0053 | 31709178 |
| FOXA1 | 5021 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| FOXA1 | 5021 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31729259 |
| FOXC2 | 3801 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| FOXE1 | 3806 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| FOXF1 | 3809 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| FOXG1 | 3811 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| FOXI1 | 3815 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| FRK | 3955 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| FSCN2 | 3960 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| FUCA1 | 4006 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31729259 |
| FUT2 | 4013 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| FUT3 | 4014 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| GALM | 24063 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| GALNT13 | 23242 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| GATA3 | 4172 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31729259 |
| GATM | 4175 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| GDA | 4212 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| GFI1 | 4237 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| GJA5 | 4279 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| GLP1R | 4324 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| GNLY | 4414 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| GPD2 | 4456 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| GREB1L | 31042 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| GREM1 | 2001 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| GRM4 | 4596 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| HAND1 | 4807 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| HCAR2 | 24827 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| HCG11 | 17707 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| HEG1 | 29227 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| HENMT1 | 26400 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| HEPHL1 | 30477 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| HES2 | 16005 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| HIPK2 | 14402 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| HPDL | 28242 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| HS6ST2 | 19133 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| HSD11B1 | 5208 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| HSD17B11 | 22960 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| HSD17B2 | 5211 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| HSPA1A | 5232 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0053 | 31709178 |
| HYAL1 | 5320 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| ICOSLG | 17087 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ID4 | 5363 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| IGFBP3 | 5472 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0095 | 31709178 |
| IL1RN | 6000 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0053 | 31709178 |
| IL20 | 6002 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| IL2RG | 6010 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| IL2RG | 6010 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| IL36G | 15741 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| IL36RN | 15561 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ILDR1 | 28741 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| INA | 6057 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| INHA | 6065 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| INHBB | 6067 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0064 | 31709178 |
| ITGA7 | 6143 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| ITGB3 | 6156 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| ITPR1 | 6180 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| IVL | 6187 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| JAK3 | 6193 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| JPH2 | 14202 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| KCNJ12 | 6258 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| KCNJ15 | 6261 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| KCNK5 | 6280 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| KCNMA1 | 6284 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| KCNMA1 | 6284 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| KCP | 17585 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| KCTD15 | 23297 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| KIF13A | 14566 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| KRT18 | 6430 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0074 | 31729259 |
| KRT19 | 6436 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0074 | 31709178 |
| KRT6C | 20406 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| LBP | 6517 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| LDOC1 | 6548 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| LGR6 | 19719 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| LINC00324 | 26628 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| LINC00473 | 8772 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| LINC01139 | 27924 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| LINC01559 | 26598 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| LMX1B | 6654 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| LPL | 6677 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| LRAT | 6685 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| LRRC3 | 14965 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| LRRC32 | 4161 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| LRRC55 | 32324 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| LRRC61 | 21704 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| MAB21L4 | 26216 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| MAFB | 6408 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| MAPK4 | 6878 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| MATK | 6906 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| MBNL3 | 20564 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| MCOLN3 | 13358 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| MEFV | 6998 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| MFI2 | 7037 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| MGAT3 | 7046 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| MGAT4A | 7047 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| MGMT | 7059 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| MICU3 | 27820 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| MID2 | 7096 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| MIR6723 | 50152 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| MLLT3 | 7136 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| MMP2 | 7166 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| MMP7 | 7174 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| MPP7 | 26542 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| MSL3P1 | 17837 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| MSLN | 7371 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| MT1F | 7398 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| MT1L | 7404 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| MUC1 | 7508 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31729259 |
| MUC2 | 7512 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| MYCL | 7555 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| MYCT1 | 23172 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| MYLK | 7590 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| MYLK | 7590 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31729259 |
| NCR3LG1 | 42400 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| NEFL | 7739 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| NFE2 | 7780 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| NKAIN1 | 25743 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| NMB | 7842 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| NOX5 | 14874 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| NPNT | 27405 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| NRAD1 | 26981 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| NSUN7 | 25857 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| NTF4 | 8024 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| NYNRIN | 20165 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| OCLN | 8104 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ODAM | 26043 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| OLFM4 | 17190 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| OLR1 | 8133 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| ONECUT2 | 8139 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| OVOL1 | 8525 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| OVOL2 | 15804 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| OVOS2 | NA | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| PABPC4L | 31955 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| PADI2 | 18341 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| PAEP | 8573 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| PAX8-AS1 | 49271 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PCDH20 | 14257 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| PCLO | 13406 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PCSK5 | 8747 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| PDE10A | 8772 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| PDE3A | 8778 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| PDE4B | 8781 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| PDE9A | 8795 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PDZD2 | 18486 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| PEX11G | 20208 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PGLYRP4 | 30015 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PIGR | 8968 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PIPOX | 17804 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PITPNM3 | 21043 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| PKP1 | 9023 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| PKP2 | 9024 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| PLA2G2A | 9031 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PLBD1 | 26215 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| PLEKHG1 | 20884 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| PLEKHM1 | 29017 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PLXDC2 | 21013 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| PNLIPRP3 | 23492 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PODXL | 9171 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31729259 |
| PPBP | 9240 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PPP1R11 | 9285 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PRKCA | 9393 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| PRKCG | 9402 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| PROM2 | 20685 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PRXL2A | 28651 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| PSD4 | 19096 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PSMB8 | 9545 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PTAFR | 9582 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| PTDSS2 | 15463 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| PTGIS | 9603 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PTGS2 | 9605 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0064 | 31709178 |
| PTPN20 | 23423 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| PTX3 | 9692 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31729259 |
| PWP2 | 9711 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PXDN | 14966 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| PYGL | 9725 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| QRFPR | 15565 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| RAB17 | 16523 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| RAB25 | 18238 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| RAB42 | 28702 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| RGCC | 20369 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| RGMA | 30308 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| RHCG | 18140 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| RNF144A | 20457 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| RNF223 | 40020 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| RNF39 | 18064 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| RORC | 10260 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| RPL39L | 17094 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| RPP25 | 30361 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| RSPO3 | 20866 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| RUNX3 | 10473 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| S100A14 | 18901 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| S100A7 | 10497 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SBK1 | 17699 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SCARA5 | 28701 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SCGB1A1 | 12523 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SCN8A | 10596 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SCNN1A | 10599 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0053 | 31729259 |
| SDK1 | 19307 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SDR16C5 | 30311 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SEMA5B | 10737 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SERPINB10 | 8942 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SERPINB3 | 10569 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0053 | 31709178 |
| SERPINB5 | 8949 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0064 | 31709178 |
| SERPINB7 | 13902 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SERPINB9 | 8955 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SERPINB9P1 | 28590 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SERPINE1 | 8583 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0053 | 31709178 |
| SERPINE1 | 8583 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0053 | 31709178 |
| SERPINE2 | 8951 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31729259 |
| SFRP1 | 10776 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SH3TC2 | 29427 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SHANK2 | 14295 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SIX2 | 10888 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SLC13A3 | 14430 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SLC16A5 | 10926 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SLC22A31 | 27091 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SLC26A9 | 14469 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SLC27A2 | 10996 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| SLC28A3 | 16484 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SLC2A10 | 13444 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SLC35D2 | 20799 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SLC44A3 | 28689 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SLC4A11 | 16438 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SLC51A | 29955 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SLC5A1 | 11036 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SLC6A12 | 11045 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| SLIT3 | 11087 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SLITRK4 | 23502 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SMAD6 | 6772 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| SMO | 11119 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0212 | 31709178 |
| SMPDL3B | 21416 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SOWAHB | 32958 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SOX9 | 11204 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0244 | 31709178 |
| SPINK13 | 27200 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SPINK6 | 29486 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| SPINT2 | 11247 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SPOCK2 | 13564 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SPRR2A | 11261 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SPRR2E | 11265 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| SRGN | 9361 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| SRMS | 11298 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SSH3 | 30581 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31729259 |
| ST3GAL2 | 10863 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| ST8SIA4 | 10871 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| STEAP4 | 21923 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| STS | 11425 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SULT1A1 | 11453 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SUSD3 | 28391 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| SYBU | 26011 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| SYCP2 | 11490 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| SYNE4 | 26703 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SYT14 | 23143 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| TACSTD2 | 11530 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| TAP1 | 43 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| TBX2 | 11597 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| TBX20 | 11598 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| TBXAS1 | 11609 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| TES | 14620 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TEX41 | 48667 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TG | 11764 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| THNSL2 | 25602 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| THRB | 11799 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| TMC4 | 22998 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| TMEM158 | 30293 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31729259 |
| TMEM169 | 25130 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TMEM171 | 27031 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| TMEM200B | 33785 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TMIE | 30800 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TMPRSS13 | 29808 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TMPRSS3 | 11877 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TMPRSS4 | 11878 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| TNC | 5318 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| TNC | 5318 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| TNFRSF11B | 11909 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| TNFRSF8 | 11923 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| TNFSF14 | 11930 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TNNC1 | 11943 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TNNC1 | 11943 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TP73-AS1 | 29052 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TRIM9 | 16288 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| TRIML2 | 26378 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| TRPM2 | 12339 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TRPM2-AS | 50758 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TRPV4 | 18083 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TSPAN5 | 17753 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| TSPOAP1 | 16831 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TSPYL5 | 29367 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| UBASH3A | 12462 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| VAMP5 | 12646 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| VANGL2 | 15511 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| VARS2 | 21642 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| VIM | 12692 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.017 | 31729259 |
| VIPR2 | 12695 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| VNN3 | 16431 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| VWF | 12726 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| WDR86 | 28020 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| WFDC2 | 15939 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| WNT6 | 12785 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| WT1 | 12796 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| YBX2 | 17948 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ZBED6CL | 21720 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ZFP82 | 28682 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ZNF114 | 12894 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ZNF320 | 13842 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ZNF608 | 29238 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ZNF681 | 26457 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ZNF750 | 25843 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ZNF860 | 34513 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| ZNF91 | 13166 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ZYG11A | 32058 | HTM | Triple Negative Breast Cancer | Carcinoma | SUM149PT | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |